Acquiring Company
Apitoria Pharma
Acquired Company
A1 Biochem Group
Description
Apitoria Pharma, a subsidiary of Aurobindo Pharma, is acquiring the Contract Research Services business of A1 Biochem Group. The transaction includes A1 Biochem USA acquiring 100% of A1 Biochem Labs LLC. This move allows A1 Biochem Labs LLC to become a step-down subsidiary of A1 Biochem Labs India. The acquisition is based on definitive agreements signed for this purpose.
Fundz sees it the moment Apitoria Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired A1 Biochem Group?
A1 Biochem Group was acquired by Apitoria Pharma. The deal was reported on October 5, 2026. Apitoria Pharma is a subsidiary of Aurobindo Pharma. It focuses on providing innovative and high-quality pharmaceutical services. The company is engaged in various phases of drug development and research. Apitoria Pharma is privately held and operates in Biotechnology.
When did Apitoria Pharma acquire A1 Biochem Group?
Apitoria Pharma's acquisition of A1 Biochem Group was reported on October 5, 2026. Apitoria Pharma, a subsidiary of Aurobindo Pharma, is acquiring the Contract Research Services business of A1 Biochem Group. The transaction includes A1 Biochem USA acquiring 100% of A1 Biochem Labs LLC. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does A1 Biochem Group do?
A1 Biochem Group specializes in biochemistry and contract research services. The company offers various biological and chemical research services. A1 Biochem is recognized for its development support in the pharmaceutical sector. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.